https://www.neurologylive.com/view/ublituximab-outperforms-teriflunomide-cnm-au8-fails-healey-als-trial-benefits-aerobic-exercise-multiple-sclerosis
0
0
Ublituximab Outperforms Teriflunomide on ARRs, CNM-Au8 Fails HEALEY ALS Trial, Benefits of Aerobic Exercise in Multiple Sclerosis - Neurology Live
+ 148 more
10/8/22 at 11:00am
Organization
Neurologylive.com
Author
NeurologyLive® Staff
34 words
0
Comments
Neurology News Network for the week ending October 8, 2022. [WATCH TIME: 3 minutes]
You are the first to view
Create an account or login to join the discussion